Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Accumulated Expenses (2023 - 2024)

Historic Accumulated Expenses for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $2.8 million.

  • Sagimet Biosciences' Accumulated Expenses fell 1294.7% to $2.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.8 million, marking a year-over-year decrease of 1294.7%. This contributed to the annual value of $5.4 million for FY2023, which is N/A changed from last year.
  • Sagimet Biosciences' Accumulated Expenses amounted to $2.8 million in Q3 2024, which was down 1294.7% from $3.6 million recorded in Q2 2024.
  • Sagimet Biosciences' 5-year Accumulated Expenses high stood at $5.4 million for Q4 2023, and its period low was $2.4 million during Q2 2023.